These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9490465)

  • 1. [Sympathy and heartache: new information on the sympathetic nervous system].
    Spieker LE; Binggeli C; Lüscher TF; Noll G
    Schweiz Med Wochenschr; 1997 Nov; 127(48):1986-92. PubMed ID: 9490465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
    Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G
    J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists and sympathetic nerve activation: are there differences between classes?
    Noll G; Wenzel RR; Shaw S; Lüscher TF
    J Hypertens Suppl; 1998 Jan; 16(1):S17-24. PubMed ID: 9534092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The physiopathological aspects and new therapeutic approaches in cardiac-circulatory failure].
    Peruzzi G; Di Nardo P; Raimondi G; Legramante JM; Iellamo F; Massaro M; Bellegrandi F; Minieri M; Pafi M; Castrucci F
    Clin Ter; 1992 Nov; 141(11):339-72. PubMed ID: 1493659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sympathetic nervous system and endothelial function in heart failure].
    Binggeli C; Wenzel RR; Noll G
    Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction between the sympathetic and renin-angiotensin system].
    K-Laflamme A; de Champlain J
    Therapie; 1998; 53(3):245-52. PubMed ID: 9773124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease.
    Malpas SC
    Physiol Rev; 2010 Apr; 90(2):513-57. PubMed ID: 20393193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological aspects of autonomic nervous system function.
    Gilbey MP; Spyer KM
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):518-23. PubMed ID: 8400463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans.
    Sartori C; Lepori M; Scherrer U
    Pharmacol Ther; 2005 May; 106(2):209-20. PubMed ID: 15866320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to quantify sympathetic cardiovascular influences.
    Mancia G; Daffonchio A; Di Rienzo M; Ferrari AU; Grassi G
    Eur Heart J; 1998 Jun; 19 Suppl F():F7-13. PubMed ID: 9651729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
    Nap A; Belterman CN; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):220-7. PubMed ID: 14689369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic renal failure--taming the sympathetic nervous system! New approach to delaying progression].
    Rump LC; Oberhauser V
    MMW Fortschr Med; 1999 Nov; 141(46):39-41. PubMed ID: 10795144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.